JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000438200 on April 6, 2000

J. Biol. Chem., Vol. 275, Issue 25, 19241-19249, June 23, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/25/19241    most recent
M000438200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bai, J.
Right arrow Articles by Cederbaum, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bai, J.
Right arrow Articles by Cederbaum, A. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Overexpression of Catalase in the Mitochondrial or Cytosolic Compartment Increases Sensitivity of HepG2 Cells to Tumor Necrosis Factor-alpha -induced Apoptosis*

Jingxiang Bai and Arthur I. CederbaumDagger

From the Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, New York 10029

Received for publication, January 20, 2000, and in revised form, March 16, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The sensitivity of HepG2 cells overexpressing catalase in either the cytosolic or mitochondrial compartment to tumor necrosis factor-alpha (TNF-alpha ) and cycloheximide was studied. Cells overexpressing catalase in the cytosol (C33 cells) and especially in mitochondria (mC5 cells) were more sensitive to TNF-alpha -induced apoptosis than were control cells (Hp cells). The activities of caspase-3 and -8 were increased by TNF-alpha , with the highest activities found in mC5 cells. Sodium azide, an inhibitor of catalase, reduced the increased sensitivity of mC5 and C33 cells to TNF-alpha to the level of toxicity found with control Hp cells. Azide also decreased the elevated caspase-3 activity of mC5 cells. A pan-caspase inhibitor prevented the TNF-alpha -induced apoptosis and toxicity produced by catalase overexpression. Addition of H2O2 prevented TNF-alpha -induced apoptosis and caspase activation, an effect prevented by simultaneous addition of catalase. TNF-alpha plus cycloheximide increased ATP levels, with higher levels in C33 and mC5 cells compared with Hp cells. TNF-alpha did not produce apoptosis in mC5 cells maintained in a low energy state. TNF-alpha signaling was not altered by the overexpression of catalase, as activation of nuclear factor kappa B and AP-1 by TNF-alpha was similar in the three cell lines. These results suggest that catalase, overexpressed in the cytosolic or especially the mitochondrial compartment, potentiates TNF-alpha -induced apoptosis and activation of caspases by removal of H2O2.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Apoptosis, a major form of cell death, is characterized by early and prominent condensation of nuclear chromatin, cell shrinkage, activation of proteases and endonucleases, enzymatic cleavage of the DNA into 180-base pair oligonucleosomal fragments, and segmentation of the cells into membrane-bound apoptotic bodies (1, 2). The most critical protease families implicated in apoptosis are cysteine proteases known as caspases (3, 4). Caspases are constitutively present in cells as zymogens and require proteolytic cleavage into the catalytic active heterodimer. Inhibiting the activation of caspases suppresses the ability of cells to undergo apoptosis or causes a switch from apoptosis to necrosis (4, 5).

Reactive oxygen species (ROS)1 are thought to be involved in many forms of apoptosis. Increased levels of ROS have been detected in cells undergoing apoptosis (5, 6). Oxidative stress also affects the process of apoptosis. For example, treatment of cells in vitro with H2O2 causes either apoptosis or necrosis depending on the concentration of H2O2 employed and the type of cells being studied (7, 8). Recent reports indicated that oxidative stress inhibits apoptosis induced by the chemotherapeutic drug VP-16 (9) or by alpha CD95 (5).

TNF-alpha is a cytokine produced by a wide variety of cell types whose production is up-regulated in a number of stressful and pathological conditions (10, 11). TNF-alpha expression is increased in animal models of toxic liver injury (12, 13) and in humans during alcohol-induced liver disease (14, 15). TNF-alpha kills cancer cells in intact animals and a variety of cell lines in vitro by inducing these cells to undergo either apoptosis or necrosis. However, the biochemical basis for the cytotoxic action of TNF-alpha is still largely unknown. TNF-alpha has to been shown to increase production of ROS, and this appears to be an important step in its cytotoxic mechanism (16, 17). Although some studies reported that antioxidants could protect against TNF-alpha toxicity (18, 19), there are other reports that antioxidants including catalase did not prevent TNF-alpha -mediated cell death (20).

In a previous study (21), stable HepG2 cell lines overexpressing catalase in the cytosol or mitochondria were established by transfection with catalase cDNA or with a catalase cDNA with a manganese-superoxide dismutase mitochondrial leader sequence that could conduct catalase into mitochondria. We found that the cells overexpressing catalase in either cellular compartment were more resistant to H2O2-, menadione-, or antimycin A-induced toxicity and apoptosis compared with cells transfected with the empty plasmid vector. In view of the conflicting reports concerning the ability of antioxidants to prevent TNF-alpha toxicity, and since one major locus of TNF-alpha -induced oxidative stress appears to be the mitochondrial compartment, studies were carried out to investigate the sensitivity of HepG2 cells that overexpress catalase in the cytosol or mitochondria to apoptosis induced by TNF-alpha . To our surprise and in contrast to the decreased sensitivity to H2O2, menadione, or antimycin A, cells overexpressing catalase, especially in the mitochondrial compartment, displayed an increased sensitivity to TNF-alpha -induced apoptosis.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents-- Recombinant human TNF-alpha , cycloheximide (CHX), sodium azide, hydrogen peroxide (H2O2), horseradish peroxidase-conjugated goat anti-rabbit IgG, MEM, and fetal bovine serum were purchased from Sigma. Propidium iodide was purchased from Molecular Probes, Inc. (Eugene, OR). Bovine catalase, caspase inhibitor I, substrates of caspase-3 and -8, and polyclonal antibodies raised in rabbit against human caspase-3 or cytochrome c were obtained from Calbiochem. Zeocin for selection was from Invitrogen (Carlsbad, CA).

Cell Lines and Cell Culture-- HepG2 cells overexpressing cytosolic catalase (C33 cells) and mitochondrial catalase (mC5 cells) as well as control cells (Hp cells) were established in our laboratory previously (21) by transfection with plasmid vector pZeoSV2(+) containing human catalase cDNA (pZeoSV-CAT), plasmid vector pZeoSV2(+) containing human catalase cDNA with a manganese-superoxide dismutase mitochondrial leader sequence (pZeoSV/MSP-CAT), and empty vector pZeoSV2(+) into HepG2 cells. Cells were cultured in MEM containing 10% fetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin, 300 µg/ml Zeocin, and 2 mM glutamine in a humidified atmosphere in 5% CO2 at 37 °C.

DNA Fragmentation Assay-- The DNA fragmentation pattern (DNA ladder) was carried out by agarose gel electrophoresis. Cells (1× 106) treated with various reagents were scraped and centrifuged at 1200 rpm for 10 min. The cell pellet was resuspended in 1 ml of lysis buffer consisting of 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 10 mM EDTA, 100 µg/ml proteinase K, and 0.5% SDS and incubated for 2 h at 50 °C. DNA was extracted with 1 ml of phenol, pH 8.0, followed by extraction with 1 ml of phenol/chloroform (1:1) and chloroform. The aqueous phase was precipitated with 2.5 volumes of ice-cold ethanol and 0.1 volume of 3 M sodium acetate, pH 5.2, at -20 °C overnight. The precipitates were collected by centrifugation at 13,000 × g for 10 min. The pellets were air-dried and resuspended in 50 µl of Tris/EDTA buffer supplemented with 100 µg/ml RNase A. DNA was loaded onto a 1.5% agarose gel containing ethidium bromide, electrophoresed in Tris acetate/EDTA buffer for 2 h at 50 V, and photographed under UV illumination.

DNA Analysis by Flow Cytometry-- Flow cytometry DNA analysis was used to quantify the percentage of apoptotic cells. Cells (5 × 105) were seeded onto six-well plates and incubated with various reagents. At different time points, cells were harvested by trypsinization and washed with PBS, followed by centrifugation at 2000 rpm for 10 min. The cell pellet was resuspended in 80% ethanol and stored at 4 °C for 24 h. Cells were washed twice with PBS. The pellet was resuspended in PBS containing 100 µg/ml RNase A, incubated at 37 °C for 30 min, stained with propidium iodide (50 µg/ml), and analyzed by flow cytometry DNA analysis as described previously (21).

Caspase Activity Assay-- Hp, C33, and mC5 cells treated as described in the figure legends were harvested by scraping from the dishes, washed with ice-cold PBS, and resuspended in lysis buffer containing 50 mM Hepes, pH 7.5, 10% sucrose, and 0.1% Triton X-100 on ice for 30 min. After centrifugation at 16,000 × g for 20 min at 4 °C, supernatants were transferred to new tubes. Protein concentration was measured with the DC protein assay reagent (Bio-Rad). Caspase-3 activity was measured in the supernatant using the CaspACETM assay system kit (Promega) by following the cleavage of 50 µM acetyl-Asp-Glu-Val-Asp 7-amino-4-methylcoumarin. The fluorescence of the cleaved 7-amino-4-methylcoumarin substrate was determined using a fluorescence spectrophotometer (Perkin-Elmer 650-10S, Hitachi, Ltd.) set at an excitation wavelength of 360 nm and an emission wavelength of 460 nm. The same method was used to measure the activity of caspase-8 using 50 µM benzyloxycarbonyl-Ile-Glu-Thr-Asp 7-amino-4-trifluoromethylcoumarin as a substrate and 400 nm as the excitation wavelength and 505 nm as the emission wavelength. Activities are expressed as arbitrary units of fluorescence.

Western Blotting-- To detect procaspase-3, cells treated with or without TNF-alpha plus CHX were washed twice with PBS, harvested by scraping, and subsequently sonicated at duty cycle 50% and output control 4 for 10 s (Heat Systems-Ultrasonics, Inc.). The sonicated suspensions were centrifuged at 10,000 × g for 10 min at 4 °C. The supernatant was transferred to a new tube, and the protein concentration was measured. To detect cytochrome c, a post-mitochondrial supernatant fraction was prepared by homogenization and differential centrifugation as described previously (21). 50 µg (for procaspase-3) or 20 µg (for cytochrome c) of denatured protein was resolved on 15% SDS-polyacrylamide gel and electroblotted onto nitrocellulose membranes (Bio-Rad). The membrane was incubated with rabbit anti-human caspase-3 (1:300) or rabbit anti-human cytochrome c (1:1000) polyclonal antibody as the primary antibody, followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG as the secondary antibody (1:5000). Detection by the chemiluminescence reaction was carried out for 1 min using the ECL kit (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom).

Gel Shift Assay-- Cells treated with medium or with medium containing 15 ng/ml TNF-alpha for 15 or 30 min were harvested by scraping and centrifugation. The cell pellets were resuspended in 800 µl of buffer containing 10 mM Hepes, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride. After incubation on ice for 15 min, 50 µl of 10% Nonidet P-40 was added; the lysed cells were mixed in a Vortex mixer for 10 s and then spun down (13,000 × g, 1 min, 4 °C); and the supernatant was removed. The nuclear pellet was quickly resuspended in 400 µl of buffer containing 20 mM Hepes, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride. The nuclei were extracted on ice for 15 min with Vortex mixing every minute. The nuclei were then pelleted by centrifugation (13,000 × g, 5 min, 4 °C); the supernatant, considered as the nuclear extract, was removed; and the protein concentration was measured.

The DNA binding reaction was performed using the gel shift assay system from Promega according to the instructions of the manufacturer. 2-5 µg of nuclear extract was incubated in gel shift binding buffer for 10 min at room temperature. NF-kappa B and AP-1 DNA probes (5'-AGT TGA GGG GAC TTT CCC AGG C-3' and 5'-CGC TTG ATG AGT CAG CCG GAA-3', respectively) were labeled with [gamma -32P]ATP by T4 polynucleotide kinase. Approximately 10,000 cpm of 32P-labeled DNA probe was then added to the nuclear extract in binding buffer and allowed to bind for 30 min. The reaction was then loaded onto a 4% nondenaturing acrylamide gel. After gel electrophoresis, the gels were dried and exposed to Kodak XAR5 film.

ATP Assay-- Intracellular ATP levels were determined using the ENLITENTM ATP assay kit (Promega). Hp, C33, and mC5 cells (~5 × 105 cells) were treated with or without TNF-alpha /CHX for 3 h. Cells were washed twice with ice-cold PBS, and 250 µl of ice-cold 2.5% (w/v) trichloroacetic acid was added to the six-well dishes. After scrapping from the dish, the cell extract was immediately centrifuged at 10,000 × g for 5 min at 4 °C. The supernatant was diluted 10 times and neutralized with Tris acetate buffer, pH 7.75. 10-µl samples and 100 µl of luciferin-luciferase reagent were used for ATP measurements according to the instructions of the manufacturer (Promega). Luminescence units were measured using a Model 1251 luminometer (LKB Wallac). The relative luminescence units were used as an index of the intracellular ATP levels.

Statistics-- Results are expressed as means ± S.E. The numbers of experiments are indicated in the figure legends. Statistical evaluation was carried out using Student's t test.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

HepG2 cells were transfected with empty plasmid or plasmid containing human catalase cDNA or human catalase cDNA with a 80-base pair manganese-superoxide dismutase mitochondrial leader sequence, and stable cells were generated (21). Catalase activity was increased from values of ~40 units/mg of total cell protein in the cells transfected with empty vector (Hp cells) to values of 100-120 units/mg of cell protein in the cells transfected with catalase cDNA (C33 cells) or catalase cDNA with the mitochondrial leader sequence (mC5 cells). Isolated mitochondria from Hp or C33 cells displayed low catalase activity (<10 units/mg of mitochondrial protein) compared with mitochondria from mC5 cells (~140 units/mg of mitochondrial protein). Western blot analyses showed similar results as the catalase activity assays, with levels of catalase protein increasing at least 2-fold in the cell extract from C33 or mC5 cells compared with Hp cells. Catalase was barely detectable in mitochondria isolated from Hp or C33 cells, whereas a prominent band with at least 10-fold increased staining intensity was found in mitochondria isolated from mC5 cells. The activity of the other major enzyme system for removal of H2O2, the glutathione peroxidase system, was found to be similar for all three cell lines; total cellular glutathione peroxidase activity was between 17.1 and 19.6 milliunits/mg of cell protein for the three cell lines, whereas mitochondrial glutathione peroxidase activity ranged between 6.1 and 6.7 milliunits/mg of mitochondrial protein for the three cell lines.

Overexpression of Catalase in the Cytosol or Mitochondria Increases Sensitivity to TNF-alpha -induced Apoptosis-- HepG2 cells are known to be resistant to TNF-alpha -induced apoptosis; however, by combining with CHX or actinomycin D, TNF-alpha induces typical apoptosis at low concentrations and at short times (22). The appearance of apoptosis morphology, including cell shrinkage, membrane blebbing, and formation of apoptotic bodies, and biochemical changes such as DNA fragmentation and the activation of caspases occurs in the presence of TNF-alpha plus CHX. Hp, C33, and mC5 cells were treated with medium or with medium containing 15 ng/ml TNF-alpha and 40 µM CHX for 4, 8, and 12 h, and apoptosis was evaluated by a DNA fragmentation assay and by flow cytometry DNA analysis. Both assays showed that C33 cells and especially mC5 cells were more sensitive to TNF-alpha /CHX-induced apoptosis than were Hp cells (Fig. 1). DNA fragmentation assays showed clear DNA ladders in C33 cells (Fig. 1A, lane 7) and mC5 cells (lane 11) as early as 4 h in response to the TNF-alpha /CHX treatment, whereas no DNA ladder or a weak DNA ladder was seen in Hp cells at 4 h and even 8 h (lanes 3 and 4), respectively. A clear DNA ladder was observed in Hp cells 12 h after the TNF-alpha /CHX treatment (lane 5), and this was intensified in C33 cells (lane 9) and especially in mC5 cells (lane 13). The hypodiploidy of cellular DNA measured by flow cytometry after propidium iodide staining was used to indicate the percentage of apoptotic cells. These percentages were 9, 17, and 18% at 4, 8, and 12 h in Hp cells, respectively (Fig. 1B, white bars), and increased to 13, 33, and 35% in C33 cells (light-gray bars) and dramatically increased to 48, 57, and 73% in mC5 cells (dark-gray bars) at 4, 8, and 12 h, respectively. The histograms of Hp, C33, and mC5 cells treated with medium (control) or with TNF-alpha /CHX for 8 h are shown in Fig. 1C.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   Overexpression of catalase increases sensitivity to TNF-alpha -induced apoptosis. Hp, C33, and mC5 cells were treated with medium or with medium containing 15 ng/ml TNF-alpha and 40 µM CHX for 4, 8, and 12 h. A, DNA fragmentation. DNA was extracted and electrophoresed on a 1.5% agarose gel. Lane 1, 100-base pair standard ladder; lanes 2-5, 6-9, and 10-13, Hp, C33, and mC5 cells, respectively, treated with medium (lanes 2, 6, and 10) or with TNF-alpha /CHX for 4 h (lanes 3, 7, and 11), 8 h (lanes 4, 8, and 12), and 12 h (lanes 5, 9, and 13). B, bar graph showing the percent of apoptotic cells as measured by flow cytometry. The first group of bars is cells incubated with control medium; the second, third, and fourth groups of bars are cells treated with TNF-alpha and CHX for 4, 8, and 12 h, respectively. C, histograms of DNA analysis by flow cytometry. Hp, C33, or mC5 cells were incubated with medium (left panels) or with medium containing 15 ng/ml TNF-alpha and 40 µM CHX (right panels) for 8 h. The percentages of cells in the zone 1 hypodiploid area are depicted on the graphs.

Overexpression of Catalase Increases TNF-alpha Activation of Caspase Activity-- Activation of caspases, especially caspase-3, occurs in many models of apoptosis. In the absence of TNF-alpha /CHX, the activity of caspase-3 was very low and similar in the three cell lines (Fig. 2). Caspase-8 activity was higher, but also similar in the three cell lines. Addition of TNF-alpha /CHX increased caspase-3 activity in Hp cells, whereas only a small increase in caspase-8 activity was observed. The TNF-alpha /CHX activation of caspase activity was greater in C33 cells than in Hp cells and was highest in mC5 cells (Fig. 2). The increase in caspase-3 activity produced by TNF-alpha /CHX was >2-fold higher in mC5 cells than in Hp cells.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Caspase activity. Hp, C33, or mC5 cells were incubated with medium (control bars) or with medium containing 15 ng/ml TNF-alpha and 40 µM CHX (TNF+CHX bars) for 6 h. The activities of caspase-3 (upper panel) and caspase-8 (lower panel) were measured as described under "Materials and Methods." Results are representative of at least three independent experiments.

Inhibiting Catalase with Sodium Azide Decreases Apoptosis and Caspase Activation Produced by TNF-alpha -- The only apparent difference between Hp cells and C33 or mC5 cells is the increased activity and content of catalase in the cytosol or mitochondria of the latter compared with the former. To validate that the increased sensitivity of C33 and mC5 cells to TNF-alpha is indeed due to overexpression of catalase, the effect of sodium azide on TNF-alpha /CHX-induced apoptosis and caspase activation was determined. Addition of sodium azide to a final concentration of 1 mM resulted in a 70% decrease in catalase activity in C33 and mC5 cells. As shown in Fig. 3A, pretreating the cells with 1 mM sodium azide for 6 h, followed by incubation with 15 ng/ml TNF-alpha and 40 µM CHX for 6 h, resulted in an inhibition of the TNF-alpha -induced DNA ladder formation in all three cell lines (compare lanes 4, 7, and 10 with lanes 3, 6, and 9). Similarly, sodium azide lowered the percentage of cells undergoing apoptosis in the presence of TNF-alpha /CHX (Fig. 3B). This prevention of apoptosis by sodium azide was observed in all three cell lines, and much of the increase in apoptosis found in C33 and mC5 cells was prevented by sodium azide (percent apoptosis induced by TNF-alpha /CHX was 16, 33, and 41% in Hp, C33, and mC5 cells in the absence of sodium azide and 8, 12, and 15% in its presence). The striking increase in caspase-3 activity induced by TNF-alpha /CHX in mC5 cells was also reduced by sodium azide (Fig. 3C).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of sodium azide, an inhibitor of catalase, on apoptosis and caspase activation induced by TNF-alpha /CHX. Hp, C33, and mC5 cells were pretreated with or without 1 mM sodium azide for 6 h, followed by incubation with 15 ng/ml TNF-alpha and 40 µM CHX for 6 h. A, DNA fragmentation. Lane 1, 100-base pair standard ladder; lanes 2-4, 5-7, and 8-10, Hp, C33, and mC5 cells, respectively, treated with medium (lanes 2, 5, and 8), TNF-alpha /CHX (lanes 3, 6, and 9), and sodium azide + TNF-alpha /CHX (lanes 4, 7, and 10). B, bar graph showing the percent of apoptotic cells as measured by flow cytometry. White bars, cells treated with medium (control); light-gray bars, cells incubated with TNF-alpha /CHX; dark-gray bars, cells incubated with sodium azide (NaAz) + TNF-alpha /CHX. Concentrations and incubation times are the same as described for A. C, caspase-3 activity in mC5 cells pretreated with or without sodium azide for 6 h, followed by incubation with 15 ng/ml TNF-alpha and 40 µM CHX for an additional 6 h. First bar, cells treated with medium as a control; second bar, cells treated with TNF-alpha /CHX; third and fourth bars, cells pretreated with 1 and 3 mM sodium azide followed by TNF-alpha /CHX (T/C), respectively.

H2O2 Inhibits Apoptosis Induced by TNF-alpha /CHX-- The increased sensitivity of C33 and mC5 cells to TNF-alpha /CHX and the prevention of TNF-alpha toxicity by sodium azide suggest that H2O2 may be a key modulator of sensitivity to TNF-alpha . To evaluate this, Hp, C33, and mC5 cells were incubated with 15 ng/ml TNF-alpha and 40 µM CHX in the absence or presence of 200 µM H2O2; and after 6 h, apoptosis was determined by the DNA fragmentation assay. H2O2 completely inhibited apoptosis in Hp cells (Fig. 4A, lanes 3 and 4) and partially inhibited apoptosis in C33 and mC5 cells (lanes 8 and 9 and lanes 13 and 14, respectively). Adding catalase to the medium abolished this inhibitory effect of H2O2 and reestablished TNF-alpha -induced apoptosis (lanes 5, 10, and 15). At this dosage and time, cells did not show significant necrosis caused by H2O2. The increase in caspase-3 activity produced by TNF-alpha /CHX in all three cell lines was largely prevented by 200 µM H2O2 (Fig. 4B). H2O2 also produced inhibition of caspase-8 activity, which was slightly increased by addition of TNF-alpha /CHX; the inhibition of caspase-8 activity by H2O2 was less than the inhibition of caspase-3 activity (Fig. 4B). The inhibition of TNF-alpha -induced caspase activation by H2O2 was confirmed by Western blot analysis of the levels of procaspase-3. Addition of TNF-alpha /CHX to Hp cells and especially to mC5 cells decreased the levels of procaspase-3 (Fig. 4C, compare lanes 2 and 6 with lanes 1 and 5), consistent with the cleavage of the procaspase form to the active caspase-3 fragments. H2O2 prevented the TNF-alpha -induced cleavage of procaspase-3 especially in Hp cells, which show the least sensitivity to TNF-alpha -induced apoptosis (lane 3).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 4.   H2O2 and a pan-caspase inhibitor prevent apoptosis and caspase activation induced by TNF-alpha /CHX. Hp, C33, and mC5 cells were treated with medium alone or with 200 µM H2O2 or 50 µM Z-VAD-fmk together with 15 ng/ml TNF-alpha and 40 µM CHX for 6 h. A, DNA fragmentation. Lane 1, 100-base pair standard ladder; lanes 2-6, 7-11, and 12-16, Hp, C33, and mC5 cells, respectively, treated with medium only (lanes 2, 7, and 12), TNF-alpha /CHX (lanes 3, 8, and 13), H2O2 + TNF-alpha /CHX (lanes 4, 9, and 14), 500 units/ml catalase + H2O2 + TNF-alpha /CHX (lanes 5, 10, and 15), and Z-VAD-fmk + TNF-alpha /CHX (lanes 6, 11, and 16). B, bar graphs showing caspase-3 (upper panel) and caspase-8 (lower panel) activities in Hp (white bars), C33 (light-gray bars), and mC5 (dark-gray bar) cells treated with medium alone (control bars) or with 15 ng/ml TNF-alpha and 40 µM CHX in the absence or presence of either 200 µM H2O2 or 50 µM Z-VAD-fmk. C, Western blot analysis of the level of procaspase-3 (32 kDa) in Hp (lanes 1-4) and mC5 (lanes 5-8) cells. Lanes 1 and 5, cells treated with medium as control; lanes 2 and 6, cells treated with TNF-alpha /CHX; lanes 3 and 7, cells treated with TNF-alpha /CHX + 200 µM H2O2; lanes 4 and 8, cells treated with TNF-alpha /CHX + 50 µM Z-VAD-fmk.

Effect of Z-VAD-fmk, a Pan-Caspase Inhibitor, on TNF-alpha /CHX Toxicity-- The activation of caspases such as caspase-3 in all three cell lines upon addition of TNF-alpha /CHX, the increased activation of caspase-3 in mC5 cells, and the inhibition by H2O2 of TNF-alpha -induced apoptosis and caspase-3 activation suggest that caspases play an important role in the developing apoptosis and in the different sensitivity of Hp, C33, and mC5 cells to TNF-alpha . This was validated by studying the effect of Z-VAD-fmk, an inhibitor of caspase-3 as well as several other caspases, on the TNF-alpha toxicity. At a final concentration of 50 µM, Z-VAD-fmk prevented the induction of apoptosis by TNF-alpha /CHX in all three cell lines (Fig. 4A, compare lanes 6, 11, and 16 with lanes 3, 8, and 13), prevented the activation of caspase-3 by TNF-alpha /CHX in all three cell lines (Fig. 4B), and prevented the TNF-alpha /CHX-induced cleavage of procaspase-3 (Fig. 4C, compare lane 4 with lane 2 and lane 8 with lane 6). Caspase-8 activity was not inhibited by Z-VAD-fmk at a concentration that strongly inhibited caspase-3 activity (Fig. 4B). In summary, the results of Fig. 4 show that the TNF-alpha /CHX-induced apoptosis and activation of caspase-3 and the increased sensitivity of C33 cells and especially mC5 cells to TNF-alpha /CHX can be prevented by H2O2 and by the caspase inhibitor Z-VAD-fmk.

Release of Cytochrome c-- Release of cytochrome c from the mitochondria to the cytosol occurs in certain systems undergoing apoptosis (23, 24). Cytochrome c in conjunction with caspase-9 can activate caspase-3 (25). The possible presence of cytochrome c in the post-mitochondrial supernatant fraction of Hp, C33, or mC5 cells was evaluated by Western blot analysis 4 and 6 h after addition of TNF-alpha plus CHX to the incubation system, a time frame when apoptosis is occurring. Very low levels of cytochrome c were detected in all three cell lines under these conditions (Fig. 5). Increased release of cytochrome c from the mitochondria does not appear to be responsible for the increased caspase-3 activity and sensitivity to apoptosis of mC5 cells treated with TNF-alpha /CHX.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Release of cytochrome c from mitochondria to the cytosol. Hp, C33, and mC5 cells were treated with 15 ng of TNF-alpha and 40 µM CHX for 0 h (lanes 3, 6, and 9), 4 h (lanes 4, 7, and 10), and 6 h (lanes 5, 8, and 11). The cytosolic fraction was then isolated by homogenization followed by differential centrifugation, and Western blot analysis for cytochrome c was carried out using anti-cytochrome c polyclonal antibody (1:1000). Pure cytochrome c (lane 1) and 10 µg of mitochondrial protein (lane 2) were used as positive controls.

Activation of NF-kappa B and AP-1 by TNF-alpha -- Activation of oxidant-sensitive transcription factors such as NF-kappa B by TNF-alpha has been observed in many experimental models (26-28). It is generally believed that activation of NF-kappa B and the subsequent activation of NF-kappa B-responsive genes are a cellular response to minimize the toxicity of TNF-alpha (29-31). Could the increased sensitivity of C33 and mC5 cells to TNF-alpha reflect a failure to activate NF-kappa B in these cells (i.e. overexpression of catalase in C33 or mC5 cells minimizes TNF-alpha production of ROS and ROS activation of NF-kappa B (32))? We initially discounted differences in protective responses by NF-kappa B activation in the three cell lines because the presence of CHX, which was required for the TNF-alpha toxicity, would prevent synthesis of short-lived death antagonists; indeed, the requirement for CHX to observe TNF-alpha toxicity is likely due to the failure to synthesize protective factors. To study this further, the ability of TNF-alpha to activate NF-kappa B and AP-1 was evaluated by electrophoretic mobility gel shift assays. As shown in Fig. 6A, all three cell lines showed a very early response to TNF-alpha addition with respect to activation of NF-kappa B; increased binding to a NF-kappa B consensus sequence could be observed 15 min after addition of TNF-alpha . Similarly, all three cell lines showed a low activation of AP-1 binding, which increased 15 and 30 min after addition of TNF-alpha (Fig. 6B). In general, activation of NF-kappa B and AP-1 by TNF-alpha appeared to be similar in the three cell lines. Importantly, this suggests that TNF-alpha binding and signal transduction are not significantly altered by the overexpression of catalase.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 6.   Analysis of NF-kappa B (A) and AP-1 (B) binding activities in Hp, C33, and mC5 cells. Nuclear extracts from Hp (lanes 1-3), C33 (lanes 4-6), and mC5 (lanes 7-9) cells treated with medium (lanes 1, 4, and 7) or with 15 ng/ml TNF-alpha for 15 min (lanes 2, 5, and 8) or 30 min (lanes 3, 6, and 9) were incubated with 32P-labeled NF-kappa B (A) or AP-1 (B) oligonucleotide probe. Unlabeled excess oligonucleotide (1.75 pmol) was used as a specific competitor (lane 10). Results were examined by electrophoretic mobility shift assays and visualized by exposure to Kodak XAR5 film. NS, not specific.

Effect of TNF-alpha /CHX on Intracellular ATP Levels-- ATP is necessary for cells to undergo apoptosis (33, 34), and ATP levels are changed during the process of apoptosis (35). Experiments were carried out to evaluate the ATP levels in the cells after incubation in the absence or presence of TNF-alpha /CHX. Under basal conditions, the intracellular ATP level in C33 cells was two times higher than in Hp or mC5 cells (Fig. 7); the ATP level in mC5 cells was the same as that in Hp cells. After 3 h of treatment with TNF-alpha /CHX, intracellular ATP levels in all cells increased, consistent with the need for ATP for apoptosis (Fig. 7). ATP levels in C33 and mC5 cells were 50% higher than in Hp cells, which may reflect the increase in apoptosis in these cells.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of TNF-alpha plus CHX on intracellular ATP levels. Hp, C33, and mC5 cells were treated with or without 15 ng/ml TNF-alpha and 40 µM CHX for 3 h. Intracellular ATP levels were measured using the luciferin-luciferase reagent as described under "Materials and Methods." The bar graph shows the relative luminescence units as a reflection of the intracellular ATP levels in Hp (white bars), C33 (light-gray bars), and mC5 (dark-gray bars) cells.

To further evaluate the possible role of energy state or ATP level in the TNF-alpha apoptosis in mC5 cells, the cells were incu-bated in MEM, in a medium lacking glucose/amino acids (phosphate-buffered saline), or in MEM plus an inhibitor of the mitochondrial respiratory chain (antimycin A). The cells were then challenged with TNF-alpha plus CHX for 6 h and assayed for apoptosis by DNA ladder formation or propidium iodide staining. mC5 cells incubated in MEM plus TNF-alpha /CHX produced the expected DNA ladder (Fig. 8A, compare lanes 2 and 3; mC5 cells incubated without TNF-alpha /CHX). However, a DNA ladder was not produced when mC5 cells were incubated with TNF-alpha /CHX either in PBS (lane 4) or in MEM plus antimycin A (lane 5). Moreover, if the PBS was removed from the system and replaced with MEM plus TNF-alpha /CHX, a DNA ladder was then observed (lane 6), showing that the PBS incubation did not irreversibly prevent sensitivity of the cells to TNF-alpha . Results with propidium iodide staining are shown in Fig. 8B. Incubation of mC5 cells with TNF-alpha /CHX in MEM resulted in a 4-fold increase in cell staining in the hypodiploid M1 zone, from a control value of 7% in the absence of TNF-alpha to a value of 27% in the presence of TNF-alpha . The percent apoptotic cells for the TNF-alpha /CHX incubation in PBS was only 11%, and that for cells incubated in MEM plus antimycin A was 10%. Energized conditions appear to be necessary for the TNF-alpha /CHX induction of apoptosis.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of PBS or antimycin A on apoptosis induced by TNF-alpha . mC5 cells were incubated with PBS for 2 h, with MEM containing 15 µM antimycin A for 8 h, or with just MEM for 6 h, followed by addition of 10 ng/ml TNF-alpha and 40 µM CHX for a further 6 h of incubation. A, DNA fragmentation. DNA was extracted and electrophoresed on a 1.5% agarose gel. Lane 1, 100-base pair standard ladder; lane 2, cells incubated with PBS alone for 8 h; lane 3, cells incubated with MEM and TNF-alpha /CHX for 6 h; lane 4, cells incubated with PBS for 2 h and then treated with PBS containing TNF-alpha /CHX for 6 h; lane 5, cells incubated with antimycin A for 8 h and then treated with medium containing TNF-alpha /CHX for 6 h; lane 6, cells incubated with PBS for 8 h and then treated with MEM containing TNF-alpha /CHX for an additional 6 h. B, histograms of DNA analysis by flow cytometry. Panel a, mC5 cells incubated with PBS; panel b, cells incubated with MEM containing TNF-alpha /CHX for 6 h; panel c, cells incubated with PBS for 2 h and then treated with PBS containing TNF-alpha /CHX for 6 h; panel d, cells incubated with antimycin A for 8 h and then treated with MEM containing TNF-alpha /CHX for 6 h. The percentages of cells in the zone 1 hypodiploid area are depicted on the graphs.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Mitochondria are a main source of ROS generation including H2O2 and an important target for interaction with H2O2; mitochondria are also a critical organelle for cells undergoing apoptosis since they can release cytochrome c or other apoptotic factors to the cytoplasm, which eventually leads to the activation of caspases (1, 23-25). Many apoptotic stimulators, similar to TNF-alpha , are able to induce the generation of ROS by interaction with the respiratory chain (6, 36), and ROS are thought to be mediators in the apoptotic pathway (37, 38). Low levels of H2O2 can cause apoptosis, whereas higher levels lead to necrosis (7, 8); and H2O2 plays a key role in the cytotoxicity and apoptosis induced by ceramide, antimycin A, arsenite, and TNF-alpha (38-40). H2O2 can induce a mitochondrial permeability transition and decrease the mitochondrial membrane potential (41-43). The primary enzymatic defense against H2O2 in mitochondria is the glutathione peroxidase system, as catalase is not present in mitochondria from most tissues. Because mitochondria are an important target for interaction with H2O2 and since they lack catalase, we developed a HepG2 cell line that expresses catalase in the mitochondrial compartment and compared the effectiveness of overexpression of catalase in mitochondria with that of overexpression of catalase in the cytosol in protecting HepG2 cells against toxin-induced injury. With respect to H2O2, menadione, or antimycin A, catalase overexpressed in the mitochondrial compartment was generally as effective as catalase overexpressed in the cytosolic compartment in protecting against the loss of cell viability produced by these agents (21).

In the present study, similar experiments were carried out with TNF-alpha as the toxic insult to HepG2 cells. In contrast to the previous results with H2O2, menadione, or antimycin A, the cells overexpressing catalase showed an increased sensitivity to TNF-alpha plus CHX. mC5 cells were the most sensitive to TNF-alpha -induced apoptosis, and these cells displayed the highest caspase-3 activity in response to TNF-alpha addition. The somewhat unique sensitivity to TNF-alpha when catalase is expressed in the mitochondrial compartment may be related to the propensity of TNF-alpha to increase ROS production in mitochondria. Hence, mitochondrial catalase may be more effective than cytosolic catalase in removal of H2O2 produced as a consequence of TNF-alpha interactions with the mitochondrial respiratory chain.

These considerations would suggest that H2O2 is preventing or limiting a full apoptotic response to TNF-alpha . To evaluate this, we first showed that azide, an inhibitor of catalase, protected against the TNF-alpha -induced apoptosis and activation of caspase-3 in all three cell lines and prevented the elevated apoptosis and caspase-3 activity in mC5 cells. Addition of H2O2 at concentrations and for incubation times that by themselves had no effect on cellular viability also protected against the TNF-alpha -induced apoptosis and activation of caspase-3 in all three cell lines and prevented the elevated apoptosis and caspase-3 activation in mC5 cells. These actions of azide and of added H2O2 are supportive of the concept that H2O2 limits a complete apoptotic response to TNF-alpha .

Why would H2O2 limit the ability of TNF-alpha to induce apoptosis? The observations that a pan-caspase inhibitor strongly prevented apoptosis in all three cell lines and that added H2O2 was a powerful inhibitor of caspase-3 activity suggested that the latter action of H2O2 was responsible for the negative effect of H2O2 on apoptosis. TNF-alpha /CHX activated caspase-3 by causing cleavage of procaspase-3 into catalytically active fragments. H2O2 and Z-VAD-fmk inhibit the cleavage of procaspase-3 induced by TNF-alpha /CHX. It is also likely that H2O2 could inhibit caspase activity directly by oxidizing cysteine residues required for the activity of these enzymes. In a cell-free system, we observed that H2O2 suppresses the activity of activated caspase-3 (data not show).

Recent studies have shown that the execution of apoptosis requires the maintenance of adequate intracellular ATP levels (44-46). Energy failure and concomitant ATP depletion affect one or more steps of the apoptotic program and preclude the activation of execution processes, which are required for apoptotic morphology changes (46). A decrease in ATP generation by inhibiting the mitochondrial respiratory chain with rotenone, antimycin A, or an inhibitor of ATP synthase prevented cells from undergoing apoptosis or switched cellular toxicity to necrosis (35). We therefore investigated the basal ATP level as well as the changes in ATP levels after treatment with TNF-alpha /CHX in the three cell lines. In the absence of TNF-alpha /CHX treatment, ATP levels were ~2-fold higher in C33 cells than in Hp or mC5 cells. Although the reason for this has not been studied, one possible explanation could involve the known sensitivity of glyceraldehyde-3-phosphate dehydrogenase, a key glycolytic enzyme, to oxidative stress and H2O2 (47). Since this enzyme is largely located in the cytosolic compartment, cytosolic catalase would probably be most effective in preventing endogenous H2O2-mediated loss of activity. Most of the ATP produced in HepG2 cells is via glucose metabolism, which requires glycolysis as the initial step. Treatment with TNF-alpha plus CHX increases intracellular ATP levels in all three cell lines; however, the levels of ATP were higher in C33 and mC5 cells than in Hp cells. These elevated ATP levels may be permissive for apoptosis (35, 44-46). We cultured mC5 cells in PBS rather than MEM or added antimycin A to the MEM system; under these conditions of lower energy production, TNF-alpha -induced apoptosis was decreased, indicating that an energized state or ATP was required for the TNF-alpha /CHX-induced apoptosis.

Based upon the above, the following model is proposed. TNF-alpha activates a signal transduction pathway ultimately resulting in cellular apoptosis. TNF-alpha increases mitochondrial production of H2O2; H2O2 may limit a full apoptotic response to TNF-alpha by two mechanisms. One mechanism involves inhibition of caspase-3 activity either via preventing cleavage of procaspase-3 or by direct inhibition of caspase-3; it is possible that the H2O2 is also modulating the activity of upstream caspases responsible for eventual cleavage of procaspase-3. A second mechanism may reflect the lower ATP levels in Hp cells compared with C33 and mC5 cells, as the TNF-alpha -increased production of ROS may limit the state 3 respiratory rate or may partially dissipate the transmembrane energy potential. Overexpression of catalase in the cytosol or especially in mitochondria efficiently removes the H2O2 produced by TNF-alpha , allowing increased activation of caspase-3 and maximal rates of ATP synthesis to occur. This sequence of events results in an enhanced response to TNF-alpha -induced apoptosis. The comparable activation of NF-kappa B and AP-1 by TNF-alpha in the three cell lines suggests that the overexpression of catalase did not alter TNF-alpha signal transduction pathways. Although further studies are necessary to evaluate the above model, the different sensitivities to toxins such as TNF-alpha versus menadione or antimycin A emphasize the complexity in attempting to predict the effectiveness of antioxidant enzymes such as catalase and their possible therapeutic effectiveness.

    ACKNOWLEDGEMENTS

We thank Dr. J. Andres Melendez (Department of Biochemistry and Molecular Biology, Albany Medical College) for providing the various plasmids and for helpful discussion and Montserrat Marí for help with the electrophoretic mobility shift assays.

    FOOTNOTES

* This work was supported by United States Public Health Service Grants AA03312 and AA06610 from the National Institute on Alcohol Abuse and Alcoholism.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, P. O. Box 1020, One Gustave L. Levy Place, New York, NY 10029. Tel.: 212-241-7285; Fax: 212-996-7214; E-mail: Acederb@smtplink.mssm.edu.

Published, JBC Papers in Press, April 6, 2000, DOI 10.1074/jbc.M000438200

    ABBREVIATIONS

The abbreviations used are: ROS, reactive oxygen species; TNF-alpha , tumor necrosis factor-alpha ; CHX, cycloheximide; MEM, minimal essential medium; PBS, phosphate-buffered saline; NF-kappa B, nuclear factor kappa B; Z-VAD-fmk, benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Green, D. R., and Reed, J. C. (1998) Science 281, 1309-1312
2. Mignotte, B., and Vayssiere, J. L. (1998) Eur. J. Biochem. 252, 1-15
3. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. (1996) Cell 87, 171
4. Thornberry, N. A., and Lazebnik, Y. (1998) Science 281, 1312-1316
5. Samali, A., Nordgren, H., Zhivotovsky, B., Peterson, E., and Orrenius, S. (1999) Biochem. Biophys. Res. Commun. 255, 6-11
6. Tan, S., Sagara, Y., Liu, Y., Maher, P., and Schubert, D. (1998) J. Cell Biol. 141, 1423-1432
7. Lennon, S. V., Martin, S. J., and Cotter, T. G. (1991) Cell Proliferation 24, 203-214
8. Hampton, M. B., and Orrenius, S. (1997) FEBS Lett. 414, 552-556
9. Lee, Y., and Shacter, E. (1999) J. Biol. Chem. 274, 19792-19798
10. Beutler, B., and Cerami, A. (1986) Nature 320, 584-588
11. Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., and Cerami, A. (1988) J. Exp. Med. 167, 1211-1227
12. Blazka, M. E., Wilmer, J. L., Holladay, S. D., Wilson, R. E., and Luster, M. I. (1995) Toxicol. Appl. Pharmacol. 133, 43-52
13. Czaja, M. J., Flanders, K. C., Biempica, L., Klein, C., Zern, M. A., and Weiner, F. R. (1989) Growth Factors 1, 219-226
14. McClain, C. J., and Cohen, D. A. (1989) Hepatology 9, 349-351
15. Yoshioka, K., Kakumu, S., Arao, M., Tsutsumi, Y., and Inoue, M. (1989) Hepatology 10, 769-773
16. Beyaert, R., and Fiers, W. (1994) FEBS Lett. 340, 9-16
17. Goossens, V., Grooten, J., De Vos, K., and Fiers, W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8115-8119
18. Zimmerman, R. J., Chan, A., and Leadon, S. A. (1989) Cancer Res. 49, 1644-1648
19. Wong, G. H., Elwell, J. H., Oberley, L. W., and Goeddel, D. V. (1989) Cell 58, 923-931
20. O'Donnell, V. B., Spycher, S., and Azzi, A. (1995) Biochem. J. 310, 133-141
21. Bai, J., Rodriguez, A. M., Melendez, J. A., and Cederbaum, A. I. (1999) J. Biol. Chem. 274, 26217-26224
22. Hill, D. B., Schmidt, J., Shedlofsky, S. I., Cohen, D. A., and McClain, C. J. (1995) Hepatology 21, 1114-1119
23. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. (1997) Science 275, 1129-1132
24. Zamzami, N., Susin, A. S., Merchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kroemer, G. (1996) J. Exp. Med. 183, 1533-1544
25. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Bernner, C., Larochette, N., Prevost, M. C., Alzari, P. M., and Kroemer, G. (1999) J. Exp. Med. 189, 381-393
26. Hu, W. H., Johnson, H., and Shu, H. B. (1999) J. Biol. Chem. 274, 30603-30610
27. Kohler, H. B., Knop, J., Martin, M., de Bruin, A., Huchzermeyer, B., Lehmann, H., Kietzmann, M., Meier, B., and Nolte, I. (1999) Vet. Immunol. Immunopathol. 71, 125-142
28. Xu, Y., Kiningham, K. K., Devalaraja, M. N., Yeh, C. C., Majima, H., Kasarskis, E. J., and St. Clair, D. K. (1999) DNA Cell Biol. 18, 709-722
29. Wang, C. Y., Guttridge, D. C., Mayo, M. W., and Baldwin, A. S., Jr. (1999) Mol. Cell. Biol. 19, 5923-5929
30. Kitamura, M. (1999) Eur. J. Immunol. 29, 1647-1655
31. Sumitomo, M., Tachibana, M., Nakashima, J., Murai, M., Miyajima, A., Kimura, F., Hayakawa, M., and Nakamura, H. (1999) J. Urol. 161, 674-679
32. Schmidt, K. N., Amstad, P., Cerutti, P., and Baeuerle, P. A. (1995) Chem. Biol. 2, 13-22
33. Eguchi, Y., Srinivasan, A., Tomaselli, K. J., Shimizu, S., and Tsujimoto, Y. (1999) Cancer Res. 59, 2174-2181
34. Solary, E. (1998) C. R. Seances Soc. Biol. Fil. 192, 1065-1076
35. Sanchez-Alcazar, J. A., Ruiz-Cabello, J., Hernandez-Munoz, I., Pobre, P. S., de la Torre, P., Siles-Rivas, E., Garcia, I., Kaplan, O., Munoz-Yague, M. T., and Solis-Herruzo, J. A. (1997) J. Biol. Chem. 272, 30167-30177
36. Garcia-Ruiz, C., Colell, A., Mari, M., Morales, A., and Fernandez-Checa, J. C. (1997) J. Biol. Chem. 272, 11369-11377
37. Hildeman, D. A., Mitchell, T., Teague, T. K., Henson, P., Day, B. J., Kappler, J., and Marrack, P. C. (1999) Immunity 10, 735-744
38. Sidoti-de Fraisse, C., Rincheval, V., Risler, Y., Mignotte, B., and Vayssiere, J. L. (1998) Oncogene 17, 1639-1651
39. Hagar, H., Ueda, N., and Shah, S. V. (1996) Am. J. Physiol. 271, F209-F215
40. Chen, Y. C., Lin-Shiau, S. Y., and Lin, J. K. (1998) J. Cell. Physiol. 177, 324-333
41. Lemasters, J. J., Qian, T., Elmore, S. P., Trost, L. C., Nishimura, Y., Herman, B., Bradham, C. A., Brenner, D. A., and Nieminen, A. L. (1998) Biofactors 8, 283-285
42. Gores, G. J., Miyoshi, H., Botla, R., Aguilar, H. I., and Bronk, S. F. (1998) Biochim. Biophys. Acta 1366, 167-175
43. Hirokawa, M., Miura, S., Yoshida, H., Kurose, I., Shigematsu, T., Hokari, R., Higuchi, H., Watanabe, N., Yokoyama, Y., Kimura, H., Kato, S., and Ishii, H. (1998) Alcohol Clin. Exp. Res. 22 (suppl.), 111S-114S
44. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S., and Nicotera, P. (1997) J. Exp. Med. 185, 1481-1486
45. Eguchi, Y., Shimizu, S., and Tsujimoto, Y. (1997) Cancer Res. 57, 1835-1840
46. Nicotera, P., Leist, M., and Ferrando-May, E. (1998) Toxicol. Lett. 102-103, 139-142
47. Chevalier, M., Lin, E. C., and Levine, R. L. (1990) J. Biol. Chem. 265, 42-46


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
K. M. Connor, N. Hempel, K. K. Nelson, G. Dabiri, A. Gamarra, J. Belarmino, L. Van De Water, B. M. Mian, and J. A. Melendez
Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells
Cancer Res., November 1, 2007; 67(21): 10260 - 10267.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. B. Waypa, R. Guzy, P. T. Mungai, M. M. Mack, J. D. Marks, M. W. Roe, and P.